Health Services Research
Latest posts by Health Services Research (see all)
- Chronic Pain and Health Care Spending: An Analysis of Longitudinal Data from the Medical… - Nov. 26, 2014
- The Need for State Health Services and Policy Research - Nov. 21, 2014
- Measuring Value in Primary Care: Enhancing Quality or Checking the Box? - Nov. 19, 2014
- Best of the 2014 AcademyHealth Annual Research Meeting - Nov. 19, 2014
Background Assessing the real-world comparative effectiveness of common interventions is challenged by unmeasured confounding. Objective To determine whether the mortality benefit shown for drug-eluting stents (DES) over bare metal stents (BMS) in observational studies persists after controls for/tests for confounding. Data Sources/Study Setting Retrospective observational study involving 38,019 patients, 65 years or older admitted for an index percutaneous coronary intervention receiving DES or BMS in Pennsylvania in 2004–2005 followed up for death through 3 years. Study Design Analysis was at the patient level.